JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹224 Cr | ₹195 Cr | ₹164 Cr | ₹141 Cr | ₹143 Cr |
What is the latest Total Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹224 Cr |
| Mar2025 | ₹195 Cr |
| Mar2024 | ₹164 Cr |
| Mar2023 | ₹141 Cr |
| Mar2022 | ₹143 Cr |
How is Total Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹224 Cr | 14.84 | |
| Mar2025 | ₹195 Cr | 18.51 | |
| Mar2024 | ₹164 Cr | 16.21 | |
| Mar2023 | ₹141 Cr | -0.84 | |
| Mar2022 | ₹143 Cr | - | |
Compare Total Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹467.5 Cr | -2.6% | -3.5% | -11.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -2.6% |
-3.5% |
-11.6% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses